[ Price : $8.95]
Cardiome Pharma and development partner Astellas Pharma have suspend patient enrollment in their ACT 5 study involving investigati...[ Price : $8.95]
The HHS inspector general publishes factors it will consider when determining whether to exclude individuals from participating in...[ Price : $8.95]
A government-wide employee survey shows that FDA employees see the agency as a good place to work.[ Price : $8.95]
CDERs Division of Drug Marketing, Advertising, and Communications says a convention graphic for Alcons Travatan Z broadens the dr...[ Price : $8.95]
Actavis recalls 18 lots of Fentanyl patches after identifying one patch that released its active ingredient faster than specificat...[ Price : $8.95]
Theravance reports positive topline results from a Phase 1 multiple-ascending dose study and a proof-of-concept Phase 2 study eval...[ Price : $8.95]
CDER retains business-process consultant McKinsey & Co. to help it find a way out of its increasing backlog of pending generic dru...[ Price : $8.95]
FDA approves a Mylan Pharmaceuticals ANDA for a generic version of Boehringer Ingelheim's Mirapex tablets, indicated for treating ...